Myocardial fibrosis as the first sign of cardiac involvement in a male patient with Fabry disease: report of a clinical case and discussion on the utility of the magnetic resonance in Fabry pathology
Open Access
- 16 July 2014
- journal article
- case report
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 14 (1) , 86
Abstract
Cardiovascular magnetic resonance (CMR) with late gadolinium enhancement (LGE) imaging is increasingly used to assess myocardial involvement in patients with Fabry disease, an X linked lipid storage disorder. However, it is often proposed as an optional tool. A different cardiomyopathic disease progression between male and female patients was hypothesised in previous studies, as in female myocardial fibrosis was found without left ventricular (LV) hypertrophy, while myocardial fibrosis was always detected in association to LV hypertrophy in men.Keywords
This publication has 16 references indexed in Scilit:
- Effects of enzyme replacement therapy in adult patients with Fabry disease on cardiac structure and function: a retrospective cohort study of the Fabry Münster Study (FaMüS) dataBMJ Open, 2012
- Guidelines to Diagnosis and Monitoring of Fabry Disease and Review of Treatment ExperiencesThe Journal of Pediatrics, 2009
- Utility of Cardiovascular Magnetic Resonance in the Diagnosis of Anderson-Fabry DiseaseCirculation, 2009
- Long-Term Effects of Enzyme Replacement Therapy on Fabry CardiomyopathyCirculation, 2009
- Fabry disease: Guidelines for the evaluation and management of multi-organ system involvementGenetics in Medicine, 2006
- Impact of Enzyme Replacement Therapy on Cardiac Morphology and Function and Late Enhancement in Fabry’s CardiomyopathyThe American Journal of Cardiology, 2006
- Clinical benefit of enzyme replacement therapy in Fabry diseaseKidney International, 2006
- Natural history of Fabry disease in females in the Fabry Outcome SurveyJournal of Medical Genetics, 2005
- Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease Evidence for a disease specific abnormality of the myocardial interstitiumEuropean Heart Journal, 2003
- Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement TherapyAnnals of Internal Medicine, 2003